Result Summary for 208140/005p
| Protocol ID: | 208140/005p |
| Clinical Study ID: | 208140/005p |
| Official Title: | Immunogenicity and reactogenicity of GSK’s DTPa-HBV vaccine and GSK’s Hib vaccine, when administered simultaneously in 2 separate injections or in one single injection, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | Haemophilus influenzae Type b Vaccine |
| Trade/Product Name: | Hiberix;Hiberix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
